Physician

Khalid Al-Khafaji, M.D.

According to 2025 Medicare claims, Khalid Al-Khafaji, M.D. (NPI: 1588070031) practices cardiology in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is LA PORTE CLINIC COMPANY LLC (NPI: 1568829224; TIN: 810745237) and primary practice location at 46350-3115. Al-Khafaji is affiliated with the CHSPSC ACO 21, LLC (ACO ID: A3698), participating under the MSSP model.

Al-Khafaji's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,085 traditional Medicare patients, billed 3,223 HCPCS/CPT codes, and received $139,990 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,925 prescription claims across 653 beneficiaries totaling $819,533 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 71 records totaling $984. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,661 to $139,990. Similarly, Part D prescription costs have risen steadily, from $1,555 to $819,533. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$70K$140K2020 Medicare payment: $5,661 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $45,100 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $115,732 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $97,084 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $139,990 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20204242$5,661
2021341730$45,100
20221,0612,172$115,732
20231,0452,551$97,084
20241,0853,223$139,990

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$410K$820K2017 Drug cost: $1,555 (USD; Tot_Drug_Cst)2018 Drug cost: $7,475 (USD; Tot_Drug_Cst)2019 Drug cost: $895 (USD; Tot_Drug_Cst)2020 Drug cost: $291 (USD; Tot_Drug_Cst)2021 Drug cost: $11,155 (USD; Tot_Drug_Cst)2022 Drug cost: $162,253 (USD; Tot_Drug_Cst)2023 Drug cost: $474,762 (USD; Tot_Drug_Cst)2024 Drug cost: $819,533 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20174788$1,555
201877170$7,475
20193267$895
2020N/R34$291
20214588$11,155
20222261,148$162,253
20234332,627$474,762
20246534,925$819,533

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more408847$83
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function352367$48
93018Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician8989$10
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report230279$9
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only589908$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban34317,797$342,612
EntrestoSacubitril/Valsartan865,716$122,044
JardianceEmpagliflozin1005,045$100,719
XareltoRivaroxaban704,597$84,647
Repatha SureclickEvolocumab482,360$46,506

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.71$984Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Khalid Al-Khafaji, M.D.?

Tedicare shows public-source Medicare data for Khalid Al-Khafaji, M.D. (NPI 1588070031), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Khalid Al-Khafaji, M.D. have ACO affiliation data?

Khalid Al-Khafaji, M.D. is shown with ACO affiliation data for CHSPSC ACO 21, LLC (MSSP, ACO ID A3698).

What billing organization is linked to Khalid Al-Khafaji, M.D.?

Khalid Al-Khafaji, M.D. is linked to LA PORTE CLINIC COMPANY LLC (billing NPI 1568829224) in the available physician profile data.

Does Khalid Al-Khafaji, M.D. have Open Payments data?

Khalid Al-Khafaji, M.D. has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.